Aside from clear cell adenocarcinoma, DES exposure has been linked to an increased risk of breast cancer in mothers who took the drug, as well as in their daughters. Additionally, there is ongoing research on the potential link between DES and other cancers such as testicular cancer and breast cancer in sons exposed in utero.